Guidance

Myocarditis and pericarditis after COVID-19 vaccination: clinical guidance

Clinical guidance on myocarditis and pericarditis after COVID-19 vaccination for healthcare professionals.

Documents

Details

Clinical guidance to support the detection and management of clinical cases of myocarditis and pericarditis associated with coronavirus (COVID-19) vaccination.

Further information for healthcare professionals is available.

Updates to this page

Published 29 November 2021
Last updated 9 January 2023 + show all updates
  1. Updated guidance.

  2. Updated myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals.

  3. Added links to 2 studies and MHRA's weekly summary report.

  4. First published.

Sign up for emails or print this page